Literature DB >> 16192409

A summary of important documents in the field of research ethics.

Bernard A Fischer1.   

Abstract

Today's researchers are obligated to conduct their studies ethically. However, it often seems a daunting task to become familiar with the important ethical codes required to do so. The purpose of this article is to examine the content of those ethical documents most relevant to the biomedical researcher. Documents examined include the Nuremberg Code, the Declaration of Helsinki, Henry Beecher's landmark paper, the Belmont Report, the U.S. Common Rule, the Guideline for Good Clinical Practice, and the National Bioethics Advisory Commission's report on research protections for the mentally ill.

Mesh:

Year:  2005        PMID: 16192409      PMCID: PMC2632196          DOI: 10.1093/schbul/sbj005

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  35 in total

1.  The National Bioethics Advisory Commission (NBAC) report.

Authors:  E M Meslin
Journal:  Biol Psychiatry       Date:  1999-10-15       Impact factor: 13.382

2.  The schizophrenia ketamine challenge study debate.

Authors:  W T Carpenter
Journal:  Biol Psychiatry       Date:  1999-10-15       Impact factor: 13.382

3.  Drug-free research in schizophrenia: an overview of the controversy.

Authors:  Paul S Appelbaum
Journal:  IRB       Date:  1996 Jan-Feb

4.  The MacArthur Treatment Competence Study. III: Abilities of patients to consent to psychiatric and medical treatments.

Authors:  Thomas Grisso; Paul S Appelbaum
Journal:  Law Hum Behav       Date:  1995-04

5.  The long-term effects of placebo in patients with chronic schizophrenia.

Authors:  R J Wyatt; I D Henter; J J Bartko
Journal:  Biol Psychiatry       Date:  1999-10-15       Impact factor: 13.382

6.  Informed consent in medication-free schizophrenia research.

Authors:  David J Moser; Rebecca L Reese; Susan K Schultz; Michelle L Benjamin; Stephan Arndt; Frank W Fleming; Nancy C Andreasen
Journal:  Am J Psychiatry       Date:  2005-06       Impact factor: 18.112

7.  Improving understanding of research consent in middle-aged and elderly patients with psychotic disorders.

Authors:  Laura B Dunn; Laurie A Lindamer; Barton W Palmer; Shahrokh Golshan; Lawrence J Schneiderman; Dilip V Jeste
Journal:  Am J Geriatr Psychiatry       Date:  2002 Mar-Apr       Impact factor: 4.105

Review 8.  A comparison of symptom provocation procedures in psychiatry and other areas of medicine: implications for their ethical use in research.

Authors:  M T Avila; R R Conley; W T Carpenter
Journal:  Biol Psychiatry       Date:  2001-10-01       Impact factor: 13.382

9.  Adverse events during a placebo phase for inpatients with chronic schizophrenia.

Authors:  N van de Laar; I Henter; J J Bartko; R J Wyatt
Journal:  Biol Psychiatry       Date:  2001-10-01       Impact factor: 13.382

10.  Capacity to provide informed consent for participation in schizophrenia and HIV research.

Authors:  David J Moser; Susan K Schultz; Stephan Arndt; Michelle L Benjamin; Frank W Fleming; Colleen S Brems; Jane S Paulsen; Paul S Appelbaum; Nancy C Andreasen
Journal:  Am J Psychiatry       Date:  2002-07       Impact factor: 18.112

View more
  12 in total

1.  Ethical and Regulatory Considerations for Using Social Media Platforms to Locate and Track Research Participants.

Authors:  Ananya Bhatia-Lin; Alexandra Boon-Dooley; Michelle K Roberts; Caroline Pronai; Dylan Fisher; Lea Parker; Allison Engstrom; Leah Ingraham; Doyanne Darnell
Journal:  Am J Bioeth       Date:  2019-06       Impact factor: 11.229

Review 2.  Emerging empirical evidence on the ethics of schizophrenia research.

Authors:  Laura B Dunn; Philip J Candilis; Laura Weiss Roberts
Journal:  Schizophr Bull       Date:  2005-10-19       Impact factor: 9.306

Review 3.  Ethical issues in using data from quality management programs.

Authors:  David R Nerenz
Journal:  Eur Spine J       Date:  2009-04-14       Impact factor: 3.134

4.  Upholding the principles of autonomy, beneficence, and justice in phase I clinical trials.

Authors:  Taofeek K Owonikoko
Journal:  Oncologist       Date:  2013-03-01

5.  The investigator and the IRB: a survey of depression and schizophrenia researchers.

Authors:  Bernard A Fischer; Praveen George
Journal:  Schizophr Res       Date:  2010-01-12       Impact factor: 4.939

6.  Institutional review boards - a mixed blessing.

Authors:  Taimur Saleem; Umair Khalid
Journal:  Int Arch Med       Date:  2011-06-20

Review 7.  Hippocratic oath and conversion of ethico-regulatory aspects onto doctors as a physician, private individual and a clinical investigator.

Authors:  Mohammed Imran; Shadab Samad; Mohammad Maaz; Ashhar Qadeer; Abul Kalam Najmi; Mohammed Aqil
Journal:  J Midlife Health       Date:  2013-10

8.  Research 101: A process for developing local guidelines for ethical research in heavily researched communities.

Authors:  Scott D Neufeld; Jule Chapman; Nicolas Crier; Samona Marsh; Jim McLeod; Lindsay A Deane
Journal:  Harm Reduct J       Date:  2019-07-01

9.  Participants' perception of pharmaceutical clinical research: a cross-sectional controlled study.

Authors:  Gerardo González-Saldivar; René Rodríguez-Gutiérrez; José Luis Viramontes-Madrid; Alejandro Salcido-Montenegro; Kevin Erick Gabriel Carlos-Reyna; Andrés Marcelo Treviño-Alvarez; Neri Alejandro Álvarez-Villalobos; José Gerardo González-González
Journal:  Patient Prefer Adherence       Date:  2016-04-29       Impact factor: 2.711

10.  Exploring the Gaps in Practical Ethical Guidance for Animal Welfare Considerations of Field Interventions and Innovations Targeting Dogs and Cats.

Authors:  Louisa Tasker; Susan F Getty; Joyce R Briggs; Valerie A W Benka
Journal:  Animals (Basel)       Date:  2018-01-27       Impact factor: 2.752

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.